OpenEvidence
CompanyOpenEvidence closed a $75 million Series A round in February 2025 led by Sequoia Capital, which valued the company at $1 billion. The platform enables verified physicians to access referenced, point‑of‑care medical information and is used daily by more than 40 percent of U.S. doctors across over 10,000 medical facilities.
Date
Feb 20, 2025
Category
healthcare
Lead investor
Sequoia
Stage
Series A
Size
$75M
HF0
Greylock
8090 Industries
Emergence Capital
Ribbit Capital
Stage 2 Capital
General Catalyst
Index Ventures
GV
Accel
Benchmark
Meritech Capital